METASTATIC THYROID GLAND CARCINOMA
Clinical trials for METASTATIC THYROID GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC THYROID GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare, aggressive thyroid cancer
Disease control OngoingThis study tests whether combining lenvatinib (a drug that blocks cancer cell growth) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can help people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. The tria…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New combo aims to reboot radioactive iodine in stubborn thyroid cancers
Disease control OngoingThis phase 2 trial tests whether the drug trametinib can help radioactive iodine (RAI) work better in people with advanced thyroid cancer that has returned or spread and no longer responds to RAI alone. About 34 adults with specific genetic types of thyroid cancer will receive tr…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
New drug combo targets Hard-to-Treat thyroid cancer
Disease control OngoingThis early-phase study tested a combination of two targeted drugs, dabrafenib and lapatinib, in 23 people with advanced thyroid cancer that could not be removed by surgery and had stopped responding to standard treatments. The goal was to find the safest dose of lapatinib when gi…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo shows promise for hard-to-treat thyroid cancer
Disease control OngoingThis study tests whether a two-drug targeted therapy (encorafenib and binimetinib) works better with or without the immunotherapy drug nivolumab for people with a specific type of advanced thyroid cancer (BRAF V600 mutant) that has spread and no longer responds to standard radioa…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Promising combo therapy targets deadly thyroid cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with aggressive thyroid cancers (anaplastic or poorly differentiated) live longer. About 50 adults with advanced or inoperable cancer will receive different drug combinati…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC